These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
87 related articles for article (PubMed ID: 10958257)
1. Monoaminergic synapses and schizophrenia: 45 years of neuroleptics. Bennett MR J Psychopharmacol; 1998; 12(3):289-304. PubMed ID: 10958257 [TBL] [Abstract][Full Text] [Related]
2. Dopamine receptors and the dopamine hypothesis of schizophrenia. Seeman P Synapse; 1987; 1(2):133-52. PubMed ID: 2905529 [TBL] [Abstract][Full Text] [Related]
3. Historical development of the dopamine hypothesis of schizophrenia. Baumeister AA; Francis JL J Hist Neurosci; 2002 Sep; 11(3):265-77. PubMed ID: 12481477 [TBL] [Abstract][Full Text] [Related]
4. [40 years of neuroleptic drugs]. Lôo H; Brochier T; Poirier MF; Olié JP Ann Med Psychol (Paris); 1993 Mar; 151(3):271-6. PubMed ID: 7903028 [TBL] [Abstract][Full Text] [Related]
5. The chlorpromazine enigma. Baumeister AA J Hist Neurosci; 2013; 22(1):14-29. PubMed ID: 23323529 [TBL] [Abstract][Full Text] [Related]
6. The introduction of neuroleptics: a psychiatric revolution. Cancro R Psychiatr Serv; 2000 Mar; 51(3):333-5. PubMed ID: 10686239 [TBL] [Abstract][Full Text] [Related]
7. Neuroleptics, dopamine, and schizophrenia. Pickar D Psychiatr Clin North Am; 1986 Mar; 9(1):35-48. PubMed ID: 2870480 [TBL] [Abstract][Full Text] [Related]
8. [Neuroleptics and dopamine. How the antipsychotic breakthrough resulted in improved knowledge about the biology of schizophrenia]. Fog R Ugeskr Laeger; 2000 Jan; 162(1):68-9. PubMed ID: 10658506 [No Abstract] [Full Text] [Related]
9. Novel pharmacological approaches to the treatment of schizophrenia. Fink-Jensen A Dan Med Bull; 2000 Jun; 47(3):151-67. PubMed ID: 10913983 [TBL] [Abstract][Full Text] [Related]
10. The neuroleptics: a historical survey. Deniker P Acta Psychiatr Scand Suppl; 1990; 358():83-7. PubMed ID: 1978498 [TBL] [Abstract][Full Text] [Related]
11. Interactions between monoamines, glutamate, and GABA in schizophrenia: new evidence. Carlsson A; Waters N; Holm-Waters S; Tedroff J; Nilsson M; Carlsson ML Annu Rev Pharmacol Toxicol; 2001; 41():237-60. PubMed ID: 11264457 [TBL] [Abstract][Full Text] [Related]
12. Role of dopamine in schizophrenia and Parkinson's disease. Birtwistle J; Baldwin D Br J Nurs; 1998 Jul 23-Aug 12; 7(14):832-4, 836, 838-41. PubMed ID: 9849144 [TBL] [Abstract][Full Text] [Related]
13. Relations of clinical features, subgroups and medication to serum monoamines in schizophrenia. Oades RD; Klimke A; Henning U; Rao ML Hum Psychopharmacol; 2002 Jan; 17(1):15-27. PubMed ID: 12404703 [TBL] [Abstract][Full Text] [Related]
14. [A history of antipsychotic long-acting injections in the treatment of schizophrenia]. Crocq MA Encephale; 2015 Feb; 41(1):84-92. PubMed ID: 25598520 [TBL] [Abstract][Full Text] [Related]
15. Antipsychotic therapy over half a century: a tale of discovery from chlorpromazine to aripiprazole. Natesan S; Kapur S Natl Med J India; 2012; 25(4):193-5. PubMed ID: 23278774 [No Abstract] [Full Text] [Related]
17. [Drug treatments, from chlorpromazine to new molecules]. Gaillard A; Poirier MF Soins Psychiatr; 2013; (286):25-9. PubMed ID: 23757890 [TBL] [Abstract][Full Text] [Related]
18. Serotonin receptors: their key role in drugs to treat schizophrenia. Meltzer HY; Li Z; Kaneda Y; Ichikawa J Prog Neuropsychopharmacol Biol Psychiatry; 2003 Oct; 27(7):1159-72. PubMed ID: 14642974 [TBL] [Abstract][Full Text] [Related]
19. Antipsychotics--history of development and field of indication, new wine--old glassess. Jašović-Gašić M; Vuković O; Pantović M; Cvetić T; Marić-Bojović N Psychiatr Danub; 2012 Oct; 24 Suppl 3():S342-4. PubMed ID: 23114814 [TBL] [Abstract][Full Text] [Related]